IR情報

2018/09/05~2019/02/05

IR情報&株価推移

日付始値高値安値終値前日比出来高時価総額25日乖離
2019
02/053,0603,0952,9732,986-2.26%100,7001547億819万+3.5%
02/042,9433,0602,8833,055+2.48%108,3001582億8317万+6.41%
02/0115:00 平成31年3月期第3四半期決算補足資料
02/0115:00 平成31年3月期第3四半期決算短信〔日本基準〕(連結)
02/012,9293,0102,9002,981+1.09%75,4001544億4914万+4.12%
01/312,9692,9692,9242,949+0.72%59,2001527億9118万+3.08%
01/302,9422,9632,9282,928-0.51%111,2001517億314万+2.23%
01/292,8872,9582,8742,943+1.94%71,2001524億8031万+2.54%
01/282,8802,8962,8512,887-0.55%43,0001495億7889万+0.21%
01/252,8902,9372,8852,903-0.03%61,5001504億787万+0.31%
01/242,8532,9202,8502,904+1.65%59,8001504億5968万-0.14%
01/232,8532,8802,8442,857-0.7%42,9001480億2455万-2.22%
01/222,9142,9142,8682,877-0.48%32,5001490億6077万-2.04%
01/212,8862,8962,8542,891+0.77%59,4001497億8613万-2.17%
01/182,8342,9252,8342,869+1.27%63,3001486億4628万-3.6%
01/172,8432,8672,7602,833-0.32%87,1001467億8108万-5.54%
01/162,8402,8762,8262,842+0.39%57,9001472億4738万-6.05%
01/152,8042,8702,8042,831-1.5%54,3001466億7746万-7.15%
01/112,9592,9752,8592,874-1.78%57,8001489億534万-6.66%
01/102,9232,9342,8872,926-0.98%60,0001515億9952万-5.73%
01/092,8942,9752,8942,955+4.01%95,1001531億205万-5.65%
01/082,8522,8702,8192,841-0.59%92,4001471億9557万-9.98%
01/072,9012,9172,8522,858+1.24%79,0001480億7636万-10.13%
01/042,8292,8822,7952,823+0.79%101,5001462億6297万-11.84%
2018
12/282,8222,8222,7812,801-1.3%51,3001451億2312万-13.17%
12/272,7252,8492,7252,838+6.53%109,6001470億4014万-12.54%
12/262,6672,6972,6282,664+0.3%103,2001380億2499万-18.36%
12/252,8242,8242,6372,656-6.91%97,2001376億1050万-19.25%
12/212,9202,9232,8162,853-2.39%119,5001478億1731万-13.88%
12/202,9883,0102,9202,923-3.69%100,4001514億4409万-12.25%
12/193,0553,0653,0203,035-0.82%84,4001572億4694万-9.32%
12/183,1603,2153,0453,060-4.82%139,2001585億4222万-8.9%
12/173,2153,2253,1703,215-0.31%71,4001665億7295万-4.77%
12/143,2553,2803,2203,225-1.07%92,4001670億9107万-4.73%
12/133,2503,2803,2353,260+0.62%98,0001689億446万-3.86%
12/123,1603,2553,1603,240+0.31%112,1001678億6823万-4.48%
12/113,3453,3503,2303,230-2.86%79,1001673億5012万-4.94%
12/103,3603,3903,3103,325-3.06%62,8001722億7219万-2.26%
12/073,4553,4953,4053,430-0.29%61,7001777億1236万+0.82%
12/063,4603,4753,4253,440-0.86%84,7001782億3047万+1.33%
12/053,4303,4903,4103,470+0.29%72,7001797億8481万+2.42%
12/043,5653,5803,4603,460-3.08%82,1001792億6670万+2.52%
12/033,5603,6203,5553,570+1.71%117,8001849億6593万+6.25%
11/303,6253,6453,4803,510-3.04%236,9001818億5725万+5%
11/293,5803,6403,5803,620+1.97%86,9001875億5648万+8.74%
11/283,5003,5653,5003,550+2.9%98,0001839億2970万+7.06%
11/273,4253,4603,4203,450+1.17%63,5001787億4858万+4.42%
11/263,3903,4303,3703,410-0.15%74,8001766億7614万+3.33%
11/223,3403,4253,3203,415+4.43%132,7001769億3519万+3.58%
11/213,2303,2803,2153,270-0.76%89,2001694億2257万-0.76%
11/2011:00 過活動膀胱治療薬「ベオーバ錠50mg」の新発売について
11/203,2803,3203,2653,295-0.45%70,8001707億1785万-0.03%
11/193,2703,3553,2703,310+1.38%59,2001714億9502万+0.46%
11/163,3003,3053,2503,265-1.06%133,8001691億6351万-0.82%
11/153,2753,3153,2553,300-0.45%50,7001709億7691万+0.15%
11/143,3553,3553,3103,315-0.75%48,2001717億5407万+0.48%
11/133,3803,3853,3203,340-3.88%50,4001730億4935万+1.12%
11/123,5003,5003,4253,475+0.43%82,4001800億4386万+5.02%
11/093,3853,4703,3703,460+2.52%75,2001792億6670万+4.53%
11/083,3603,4003,3403,375+3.05%71,7001748億6274万+1.81%
11/073,3303,3553,2353,275-3.53%249,8001696億8163万-1.47%
11/0615:00 平成31年3月期第2四半期決算補足資料
11/0615:00 平成31年3月期第2四半期決算短信〔日本基準〕(連結)
11/063,3853,4403,3403,395+2.41%90,3001758億9897万+1.8%
11/053,3853,3853,2903,315-0.75%98,4001717億5407万-0.78%
11/023,3053,3453,2853,340+2.77%124,7001730億4935万-0.36%
11/013,2453,2653,2253,250-0.15%158,4001683億8635万-3.3%
10/313,1953,2603,1953,255+3.01%104,5001686億4540万-3.53%
10/303,1053,1853,1003,160+2.27%112,0001637億2334万-6.65%
10/309:00 低分子チロシンキナーゼ阻害剤「ホスタマチニブ」に関する技術導入契約締結のお知らせ
10/293,1353,1703,0903,090-1.44%75,7001600億9656万-8.9%
10/263,1853,1853,0953,135-0.79%79,8001624億2806万-7.82%
10/253,2303,2453,1503,160-3.95%90,0001637億2334万-7.39%
10/243,3053,3053,2503,290+1.08%66,8001704億5879万-3.8%
10/233,3303,3303,2453,255-2.84%76,0001686億4540万-4.71%
10/223,3453,3703,3103,350+0.15%60,6001735億6746万-1.85%
10/193,3553,3703,3203,345-0.15%47,5001733億841万-1.76%
10/183,3403,3753,3303,350+1.21%71,3001735億6746万-1.44%
10/173,3003,3353,2703,310+1.38%68,7001714億9502万-2.45%
10/163,2403,2753,2403,265+0.77%53,7001691億6351万-3.6%
10/153,2603,3253,2353,240-2.41%133,2001678億6823万-4.23%
10/123,3253,3603,2853,320-2.5%106,1001720億1313万-1.8%
10/113,4053,4453,3553,405-0.73%134,3001764億1708万+0.8%
10/103,4453,5103,3853,430-1.44%148,5001777億1236万+1.78%
10/093,4403,5003,4353,480-0.85%122,2001803億292万+3.45%
10/053,5053,5353,4853,510-1.82%95,1001818億5725万+4.56%
10/043,6103,6203,5353,575-0.69%136,7001852億2498万+6.75%
10/033,5953,6903,5803,600+1.69%159,5001865億2026万+7.98%
10/023,5603,5953,5153,540-0.14%84,8001834億1159万+6.59%
10/013,5853,6103,5053,545-1.53%66,6001836億7065万+7%
09/283,6053,6903,5853,600+0.7%138,9001865億2026万+8.96%
09/273,5953,6303,5603,575+0.14%77,4001852億2498万+8.66%
09/263,4953,5803,4653,570+1.28%88,9001849億6593万+9.07%
09/253,3653,5303,3603,525+5.86%137,2001826億3442万+8.26%
09/2115:00 過活動膀胱治療薬「ベオーバ錠50mg」の製造販売承認取得について
09/213,3203,3703,2853,330+0.3%67,8001725億3124万+2.71%
09/203,4153,4153,3153,320-2.5%96,7001720億1313万+2.63%
09/193,3853,4253,3403,405+1.34%86,1001764億1708万+5.42%
09/183,2153,3653,2153,360+5%89,5001740億8558万+4.22%
09/143,1953,2403,1703,200+1.11%112,7001657億9579万-0.56%
09/133,1703,2253,1303,165+0.32%95,2001639億8240万-1.65%
09/123,1853,1953,1353,155-1.25%105,1001634億6428万-2.11%
09/113,2153,2453,1603,195-0.62%128,4001655億3673万-0.99%
09/103,1753,2403,1653,215+1.74%73,0001665億7295万-0.53%
09/073,1303,1753,1203,160+0.32%58,7001637億2334万-2.38%
09/063,1653,2053,1303,150-1.56%77,7001632億523万-2.99%
09/053,2353,2403,1903,200-1.39%62,6001657億9579万-1.75%